Structure |
Chemical Name |
CAS |
MF |
|
Fluvastatin 3-Hydroxy-4,6-diene |
1207963-21-0 |
C24H24FNO3 |
|
Cyclosporine iMpurity |
|
|
|
ThiaMine IMpurity |
|
C12H17ClN4OS |
|
CitalopraM IMpurity |
|
|
|
3-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonaMide |
|
C16H14N2O3S |
|
Tigecycline |
|
|
|
1-((2R,3R,4R,5R)-3-chloro-4-hydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione |
1496551-72-4 |
C10H13ClN2O5 |
|
1-NaphthaleneMethanaMine, 7,8-dihydro-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl]propyl]-, hydrochloride (1:1), (αR)- |
1020414-33-8 |
C22H25ClF3N |
|
4,6-dichloro-2-(propylsulfinyl)pyriMidin-5-aMine |
1823431-32-8 |
C7H9Cl2N3OS |
|
Acetic acid, [[(3aR,4S,6R,6aS)-tetrahydro-2,2-diMethyl-6-[[(phenylMethoxy)carbonyl]aMino]-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-, ethyl ester |
866551-95-3 |
C20H27NO7 |
|
4',6'-Dinitro-2'-phenoxymethanesulfonanilide |
51765-56-1 |
C13H11N3O7S |
|
5-[1-Hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]salicylic acid methyl ester hydrochloride |
33778-93-7 |
C20H26ClNO4 |
|
Blonanserin Impurity I |
|
|
|
25,26,26,26,27,27-hexadeuterocholest-5-ene-3,27-diol |
1246302-95-3 |
C27H40D6O2 |
|
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2R)-2-aMino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-, (1R,3R,5R)- |
1564265-95-7 |
C18H25N3O2 |
|
3-(3-メチルベンゾイル)-1,1,1-トリフルオロアセトン |
53764-99-1 |
C11H9F3O2 |
|
7-[(7S)-7-アミノ-5-アザスピロ[2.4]ヘプタン-5-イル]-8-クロロ-6-フルオロ-1-[(1S,2R)-2-フルオロシクロプロピル]-4-オキソ-1,4-ジヒドロキノリン-3-カルボン酸 |
127254-11-9 |
C19H18ClF2N3O3 |
|
(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid |
254452-86-3 |
C25H24FNO4 |
|
Tafluprost Impurity 17 |
|
|
|
(E)-4-Acetoxy Tamoxifen |
76117-70-9 |
C28H31NO3 |
|
O-Acetyl Losartan |
1006062-27-6 |
C24H25ClN6O2 |
|
(2-クロロ-5-ヨードフェニル)(4-エトキシフェニル)メタノン |
1103738-26-6 |
C15H12ClIO2 |
|
6-(2,4-ジクロロフェニル)-1,2,4-トリアジン-3,5-ジアミン |
38943-76-9 |
C9H7Cl2N5 |
|
D-2'-DEOXYRIBOFURANOSYL-3-GUANYLUREA (Α/Β-MIXTURE) |
570410-72-9 |
C7H14N4O4 |
|
rac 5-Keto Fluvastatin |
1160169-39-0 |
C24H24FNO4 |
|
9-Piperazino Ofloxacin |
197291-75-1 |
C18H20FN3O4 |
|
Thyroxine-4-hydroxy-3,5-diiodophenyl Ether DISCONTINUED |
911661-90-0 |
C21H13I6NO5 |
|
ペリンドプリルジケトピペラジン |
129970-98-5 |
C19H30N2O4 |
|
Exemestane Impurity A |
|
|
|
(1R,3S)-1-(1,3-ベンゾジオキソール-5-イル)-2-(2-クロロアセチル)-2,3,4,9-テトラヒドロ-1H-ピリド[3,4-B]インドール-3-カルボン酸メチルエステル |
629652-44-4 |
C22H19ClN2O5 |
|
3-DesMorpholinyl-3-hydroxyethylaMino Gefitinib |
847949-56-8 |
C20H22ClFN4O3 |
|
2,4-ビス(2-フラニルメチルアミノ)-5-スルファモイル安息香酸 |
5046-19-5 |
C17H17N3O6S |
|
Cephalexin Sulfoxide |
56193-21-6 |
C16H17N3O5S |
|
N-Butyl Nor ScopolaMine Hydrochloride |
22235-98-9 |
C20H28ClNO4 |
|
(17R)-3-オキソ-11β,17-ジヒドロキシ-19-ノルプレグナ-4,9-ジエン-21-ニトリル |
86153-39-1 |
C20H25NO3 |
|
2H,5H-Pyrano[4,3-b]pyranyl Mupirocin SodiuM IMpurity |
116182-44-6 |
C26H43NaO9 |
|
3-Hydroxy CitalopraM |
411221-53-9 |
C20H21FN2O2 |
|
5-(オキシラニルメトキシ)-2,3,4,9-テトラヒドロカルバゾール |
58457-32-2 |
C15H17NO2 |
|
6α-Methyl Hydrocortisone 21-HeMisuccinate |
119657-85-1 |
C26H36O8 |
|
Hydroxy TorseMide |
99300-68-2 |
C16H20N4O4S |
|
Hydroxy Varenicline N-Trifluoroacetate |
357426-10-9 |
C15H12F3N3O2 |
|
N-ForMyl Valacyclovir |
847670-62-6 |
C14H20N6O5 |
|
2-フルオロビフェニル-4-カルボン酸 |
137045-30-8 |
C13H9FO2 |
|
テオフィルリジン塩酸塩 |
116131-08-9 |
C6H10ClN4O |
|
1,4'-Dimethyl-2'-propyl-2,5'-bi-1H-benzimidazole |
887583-89-3 |
C19H20N4 |
|
Tetracyclics compound impurities |
|
|
|
Urapidil Impurity |
770-42-3 |
C8H9BrFN.BrH |
|
N'-(1-Methylazepan-4-yl)benzohydrazine |
117078-69-0 |
C14H22ClN3O |
|
7-[(7R)-7-アミノ-5-アザスピロ[2.4]ヘプト-5-イル]-8-クロロ-6-フルオロ-1-[(1S,2R)-2-フルオロシクロプロピル]-1,4-ジヒドロ-4-オキソ-3-キノリンカルボン酸 |
127199-06-8 |
C19H18ClF2N3O3 |
|
rac 4-[4-(Oxiranylmethoxy)-1,2,5-thiadiazol-3-yl]morpholine |
58827-68-2 |
C9H13N3O3S |
|
rac a-Hydroxy Ibuprofen |
60057-62-7 |
C13H18O3 |
|
3a,7a-dihydroxy-5-(1-methyl-1H-indole-3-carbonyl)-hexahydro-1H-benzo[d]imidazol-2(3H)-one |
171967-74-1 |
C17H19N3O4 |
|
5-(5-Chlorosulfonyl-2-ethoxyphenyl)-3-propyl-1,6-dihydro_x000b_-7H-pyrazolo[4,3-d]pyrimidin-7-one |
139756-31-3 |
C16H17ClN4O4S |
|
5,7-ジフルオロクロマン-4-オン |
844648-22-2 |
C9H6F2O2 |
|
3-アセチルオキシ-2-ブテン酸エチル |
29214-62-8 |
C8H12O4 |
|
2-(ブロモメチル)-2-(2,4-ジクロロフェニル)-1,3-ジオキソラン-4-メタノール |
68751-57-5 |
C11H11BrCl2O3 |
|
INDEX NAME NOT YET ASSIGNED |
2511244-96-3 |
C27H36N2O6 |
|
Oseltamivir Impurity 91 |
|
|
|
Oseltamivir Impurity 80 |
|
|
|
Oseltamivir Impurity 72 |
|
|
|
4(1H)-Quinazolinone, 6,8-dibromo-3-cyclohexyl-2,3-dihydro- |
2512203-87-9 |
C14H16Br2N2O |
|
Linagliptin impurity KH-3 |
2279114-27-9 |
C30H37N7O6 |
|
11β-ヒドロキシ-21-アセトキシプレグナ-1,4,16-トリエン-3,20-ジオン |
3044-42-6 |
C23H28O5 |
|
1-[(1,1-ジメチルエチル)アミノ]-3-[[4-(4-モルホリニル)-1,2,5-チアジアゾール-3-イル]オキシ]-2-プロパノール?マレイン酸 |
57073-55-9 |
C17H28N4O7S |
|
Ampicillin Impurity U |
|
|
|
Canagliflozin Hydroperoxide Impurity |
|
|
|
(E)-2-hydroxy-4-(phenyldiazenyl)benzoic acid |
40038-46-8 |
C13H10N2O3 |
|
Sitagliptin EP Impurity 6 |
|
|
|
Vonoprazan-005 |
2514735-09-0 |
C33H27F3N4 |
|
D-erythro-Hexonic acid, 6-S-2-benzothiazolyl-2,4-dideoxy-6-thio-, 1,1-dimethylethyl ester |
1469771-46-7 |
C17H23NO4S2 |
|
(1R,2R,4S,5S,7s,9R)-9-butyl-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide |
|
|
|
1-Demethyl Hydroxy Daunomycinone |
58199-98-7 |
C20H16O9 |
|
(S)-2-(butylsulfonamido)-3-(4-(4-(1-methylpiperidin-4-yl)butoxy)phenyl)propanoic acid |
1631053-75-2 |
C23H38N2O5S |
|
Loxoprofen Sodium Impurity 35 |
|
|
|
Dashatinib impurity 46 |
|
|
|
(R,S)Nアセチル3,4ジメトキシフェニルアラニン |
27313-65-1 |
C13H17NO5 |
|
Oxytocin oxide impurity reference substance |
|
|
|
Troxipide Impurity 7 |
|
|
|
Bendamustine Impurity 37A |
|
|
|
Palbociclib Impurity 37 |
|
|
|
Pazufloxacin Impurity 16 |
165071-10-3 |
C14H10FNO6 |
|
Pimecrolimus Impurity 4 |
|
|
|
Posaconazole Impurity 73 |
|
|
|
Rosuvastatin Impurity 90 |
2226413-62-1 |
C38H44F2N6O8S2 |
|
Tofacitinib Impurity 110 |
|
|
|
Tofacitinib Impurity 115 |
|
|
|
Trelagliptin Impurity 27 |
|
|
|
Vildagliptin Impurity 30 |
918830-94-1 |
C10H17NO2 |
|
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d] pyrimidin-2-amine |
|
C13H19N5 |
|
Tolvaptan Impurity 6 |
1432725-24-0 |
C18H19ClN2O2 |
|
Esmolol impurity B |
|
|
|
Esmolol impurity F |
|
|
|
Diquafosol Impurity E |
|
|
|
Bortezomib Impurity 39 |
|
|
|
INDEX NAME NOT YET ASSIGNED |
2463617-49-2 |
C51H56N16O4 |
|
Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]- |
906673-43-6 |
C14H11BO5 |
|
1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- |
2138805-26-0 |
C25H29ClN8O2 |
|
1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo- |
1651211-78-7 |
C19H27I2N3O9 |
|
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
|
(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide |
|
|